Two by Two Factorial Design using Metformin and Curcumin for Second Primary Head and Neck Cancer Prevention Trial

V Kekatpure, N Subramaniam, S Sunny… - Asian Pacific Journal …, 2024 - journal.waocp.org
Objective: The 2x2 factorial design is an effective method that allows for multiple
comparisons, especially in the context of interactions between different interventions, without …

Tumor metabolism in the microenvironment of nodal metastasis in oral squamous cell carcinoma

J Curry, P Tassone, K Gill, M Tuluc… - … –Head and Neck …, 2017 - journals.sagepub.com
Objective In many cancers, including head and neck squamous cell carcinoma (HNSCC),
different regions within a tumor have different metabolic phenotypes. Transfer of metabolites …

[HTML][HTML] Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer

M Akce, B Farran, JM Switchenko, M Rupji… - … for Immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Background Preclinical studies showed metformin reduces exhaustion of tumor-infiltrating
lymphocytes and potentiates programmed cell death protein-1 (PD-1) blockade. We …

[HTML][HTML] Chemopreventive agents in oral premalignancy: A medical management review

C Suvarna, NCSK Chaitanya, S Ameer… - … Society of Preventive …, 2020 - journals.lww.com
Aims and Objective: The term chemoprevention denotes the use of specific natural or
synthetic chemical agents to prevent carcinogenesis. Chemoprevention may help delay the …

Metformin effects on metabolic coupling and tumor growth in oral cavity squamous cell carcinoma coinjection xenografts

P Tassone, M Domingo-Vidal… - … –Head and Neck …, 2018 - journals.sagepub.com
Objective Many aggressive head and neck cancers contain 2 metabolically coupled tumor
compartments: a glycolytic stromal compartment with low caveolin-1 (CAV1) and high …

[HTML][HTML] Perspectives on window of opportunity trials in head and neck cancer: lessons from the EORTC 90111-24111-NOCI-HNCG study

S Schmitz, C Caballero, LD Locati - European Journal of Cancer, 2018 - Elsevier
Assessing tumour response using a traditional phase I, II and III trial approach is not without
limitations, particularly when targeted therapies are involved. Window of opportunity trials …

Understanding metformin mediated natural killer cell activation in head and neck squamous cell carcinoma

MK Crist - 2023 - rave.ohiolink.edu
Head and neck cancer (HNC) is the 6th most common cancer worldwide, the majority of
which are head and neck squamous cell carcinomas (HNSCC). Recurrent or metastatic …

Dysplastic Lesions of the Larynx

C Olson, R Alexander, S Stinnett - Otolaryngologic Clinics of …, 2023 - oto.theclinics.com
The vocal fold epithelium is nonkeratinized stratified squamous epithelium divided into 2
main layers, the basal layer and the suprabasal layer. Epithelial cells proliferate from the …

Prognostic relevance of insulin resistance on disease‐free survival in head and neck squamous cell carcinomas: Preliminary results

FX Avilés‐Jurado, JC Flores, J Gumà… - Head & …, 2017 - Wiley Online Library
Background The primary purpose of this study was to investigate the significance of
pretreatment glycemic parameters in the prognosis of head and neck squamous cell …

Mapping the Heterogeneous Distribution of Cancer Drugs by Imaging Mass Spectrometry

PS DAMALE, S BANERJEE - Drug Metabolism Handbook …, 2022 - Wiley Online Library
The complex neoplastic tissue and its microenvironment often posit intratumor
heterogeneity, affecting drug molecule distribution in the tumor. A deep understanding of the …